| Full course regimen | Sub-therapeutic regimen |  | ||
---|---|---|---|---|---|
YEAR | N | F | N | F | Â |
1983 (N = 289) | 269 | 93.1% | 20 | 6.9% | Pre-resistance phase |
1985 (N = 298) | 293 | 98.3% | 5 | 1.7% | Â |
1987 (N = 295) | 284 | 96.3% | 11 | 3.7% | Phase of emerging resistance |
1989 (N = 220) | 214 | 97.3% | 6 | 2.7% | Â |
1992 (N = 258) | 202 | 78.3% | 56 | 21.7% | Â |
1995 (N = 243) | 177 | 72.8% | 66 | 27.2% | Phase of resistance dissemination |
1997 (N = 241) | 136 | 56.4% | 105 | 43.6% | Â |